Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
mRNA | MCM9 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | ABHD12 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | GNS | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | CHTOP | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | MMS22L | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | RP11-159D12.5 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
mRNA | COQ3 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
mRNA | CPQ | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |